Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-12-21

Clinical Trial Update: Effects of Vitamin D on Inflammation in Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether vitamin D can reduce liver inflammation in patients with hepatitis C infection and vitamin D deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Veterans Medical Research Foundation | Conditions: Hepatitis C Infection, Vitamin D Deficiency | Phase 2 | Status: UNKNOWN